Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Lomustine with Radiation for Pediatric High-Grade Glioma
NCT00100802Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Mar 2005
- Primary completion
- Sep 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lomustine in glioma, sponsored by Children's Oncology Group. Started Mar 2005; status: completed.
02
Drugs
lomustine
03
Conditions
glioma
Beyond the preview
Go deeper on NCT00100802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100802.